ReviewInternational journal of women's health2014

Pertuzumab in human epidermal growth-factor receptor 2-positive breast cancer: clinical and economic considerations.

Nathan Wd Lamond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.